| ISIN | LU2462149217 |
|---|---|
| Valor Number | |
| Bloomberg Global ID | |
| Fund Name | Galileo – Biotech Innovation Fund RM USD |
| Fund Provider |
IPConcept (Luxemburg) S.A.
Zürich, Switzerland Phone: +352 260248-1 E-Mail: info.lu@ipconcept.com Web: www.ipconcept.com |
| Fund Provider | IPConcept (Luxemburg) S.A. |
| Representative in Switzerland |
IPConcept (Schweiz) AG Zürich Phone: +41 044 224 32 09 |
| Distributor(s) | Bellecapital AG |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
| Redemption Condition | The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel) |
| Investment Strategy *** | |
| Peculiarities |
| Current Price * | 112.34 USD | 07.10.2025 |
|---|---|---|
| Previous Price * | 112.31 USD | 06.10.2025 |
| 52 Week High * | 116.46 USD | 12.11.2024 |
| 52 Week Low * | 65.91 USD | 09.04.2025 |
| NAV * | 112.34 USD | 07.10.2025 |
| Issue Price * | 112.34 USD | 07.10.2025 |
| Redemption Price * | 112.34 USD | 07.10.2025 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | ||
| Unit/Share Assets *** | ||
| Trading Information SIX | ||
| YTD Performance | +20.00% |
30.12.2024 - 07.10.2025
30.12.2024 07.10.2025 |
|---|---|---|
| YTD Performance (in CHF) | +5.50% |
30.12.2024 - 07.10.2025
30.12.2024 07.10.2025 |
| 1 month | +20.60% |
08.09.2025 - 07.10.2025
08.09.2025 07.10.2025 |
| 3 months | +36.22% |
07.07.2025 - 07.10.2025
07.07.2025 07.10.2025 |
| 6 months | +60.37% |
07.04.2025 - 07.10.2025
07.04.2025 07.10.2025 |
| 1 year | +3.10% |
07.10.2024 - 07.10.2025
07.10.2024 07.10.2025 |
| 2 years | -25.65% |
11.03.2024 - 07.10.2025
11.03.2024 07.10.2025 |
| 3 years | - | - |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| No top holdings available for this fund |
| TER | |
|---|---|
| TER date | |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | |